{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:33:20Z","timestamp":1791275600762,"version":"4.1.0"},"reference-count":17,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1253\/circj.cj-14-1329","type":"journal-article","created":{"date-parts":[[2014,12,14]],"date-time":"2014-12-14T18:19:04Z","timestamp":1418581144000},"page":"34-40","source":"Crossref","is-referenced-by-count":17,"title":["Report of the American Heart Association (AHA) Scientific Sessions 2014, Chicago"],"prefix":"10.1253","volume":"79","author":[{"given":"Takashi","family":"Kohno","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ishimori N, Kinugawa S, Yamada S, Yokoshiki H, Mitsuyama H, Tsutsui H. Report of the American Heart Association (AHA) scientific sessions 2013, Dallas. <i>Circ J<\/i> 2014; 78: 51\u201356.","DOI":"10.1253\/circj.CJ-13-1466"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Muramatsu T, Ozaki Y. European Society of Cardiology (ESC) congress report from Barcelona 2014. <i>Circ J<\/i> 2014; 78: 2610\u20132618.","DOI":"10.1253\/circj.CJ-14-1088"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kusunose K. Report of the American College of Cardiology (ACC) Scientific Sessions 2014, Washington, DC. <i>Circ J<\/i> 2014; 78: 1311\u20131316.","DOI":"10.1253\/circj.CJ-14-0411"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2013; 369: 2093\u20132104.","DOI":"10.1056\/NEJMoa1310907"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hemmi N, Tohyama S, Nakajima K, Kanazawa H, Suzuki T, Hattori F, et al. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. <i>Stem Cells Transl Med<\/i> 2014; 3: 1473\u20131483.","DOI":"10.5966\/sctm.2014-0072"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. <i>J Clin Invest<\/i> 2010; 120: 254\u2013265.","DOI":"10.1172\/JCI40295"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, et al; the DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. <i>N Engl J Med<\/i> 2014; 371: 2155\u20132166.","DOI":"10.1056\/NEJMoa1409312"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, et al; J-Cypher Registry Investigators. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: Five-year outcome of the J-CYPHER registry. <i>Circulation<\/i> 2012; 125: 584\u2013591.","DOI":"10.1161\/CIRCULATIONAHA.111.046599"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Garratt KN, Weaver WD, Jenkins RD, Pow TK, Mauri L, Kereiakes DJ, et al. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after taxus liberte paclitaxel-eluting coronary stent placement. <i>Circulation<\/i>2014 November 16, doi:10.1161\/CIRCULATIONAHA.114.013570.","DOI":"10.1161\/CIRCULATIONAHA.114.013570"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, et al. Low-dose aspirin for primary prevention of cardiovascular events in japanese patients 60 years or older with atherosclerotic risk factors: A randomized clinical trial. <i>JAMA<\/i>2014 November 17, doi:10.1001\/jama.2014.15690.","DOI":"10.1001\/jama.2014.15690"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Muhlestein JB, Lappe DL, Lima JA, Rosen BD, May HT, Knight S, et al. Effect of screening for coronary artery disease using ct angiography on mortality and cardiac events in high-risk patients with diabetes: The FACTOR-64 randomized clinical trial. <i>JAMA<\/i> 2014; 312: 2234\u20132243.","DOI":"10.1001\/jama.2014.15825"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD, et al; the Pediatric Heart Network Investigators. Atenolol versus losartan in children and young adults with marfan\u2019s syndrome. <i>N Engl J Med<\/i> 2014; 371: 2061\u20132071.","DOI":"10.1056\/NEJMoa1404731"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, et al; the Cardiothoracic Surgical Trials Network Investigators. Surgical treatment of moderate ischemic mitral regurgitation. <i>N Engl J Med<\/i> 2014; 371: 2178\u20132188.","DOI":"10.1056\/NEJMoa1410490"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kaiser C, Galatius S, Jeger R, Gilgen N, Jensen JS, Naber CK, et al. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: Main results of the Basel Stent Kosten-Effektivitats Trial- Prospective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial. <i>Circulation<\/i>2014 November 19, doi:10.1161\/CIRCULATIONAHA.114.013520.","DOI":"10.1161\/CIRCULATIONAHA.114.013520"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al; PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. <i>N Engl J Med<\/i> 2014; 371: 993\u20131004.","DOI":"10.1056\/NEJMoa1409077"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Butt M, Dwivedi G, Shantsila A, Khair OA, Lip GY. Left ventricular systolic and diastolic function in obstructive sleep apnea: Impact of continuous positive airway pressure therapy. <i>Circ Heart Fail<\/i> 2012; 5: 226\u2013233.","DOI":"10.1161\/CIRCHEARTFAILURE.111.964106"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yoshihisa A, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, et al. Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing. <i>Eur J Heart Fail<\/i> 2013; 15: 543\u2013550.","DOI":"10.1093\/eurjhf\/hfs197"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/1\/79_CJ-14-1329\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T22:05:50Z","timestamp":1498169150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/1\/79_CJ-14-1329\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-14-1329","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}